Bronte Capital Management Pty Ltd. Bio N Tech Se Transaction History

Bronte Capital Management Pty Ltd.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$80.36 - $102.87 $250,241 - $320,337	-3,114 Reduced 3.87%	77,292 $6.21 Million
Q1 2024 May 13, 2024	BUY	$88.96 - $112.35 $5.07 Million - $6.41 Million	57,042 Added 244.14%	80,406 $7.42 Million
Q4 2023 Feb 07, 2024	SELL	$90.91 - $112.75 $12,272 - $15,221	-135 Reduced 0.57%	23,364 $2.47 Million
Q2 2023 Aug 07, 2023	BUY	$102.58 - $129.66 $19,490 - $24,635	190 Added 0.82%	23,499 $2.54 Million
Q1 2023 May 12, 2023	BUY	$122.57 - $153.67 $2.03 Million - $2.54 Million	16,558 Added 245.27%	23,309 $2.9 Million
Q4 2022 Feb 13, 2023	SELL	$118.43 - $186.05 $23,330 - $36,651	-197 Reduced 2.84%	6,751 $1.01 Million
Q2 2022 Aug 08, 2022	BUY	$123.25 - $186.24 $1,725 - $2,607	14 Added 0.2%	6,948 $1.04 Million
Q1 2022 May 13, 2022	BUY	$126.25 - $231.85 $29,290 - $53,789	232 Added 3.46%	6,934 $1.18 Million
Q4 2021 Feb 10, 2022	SELL	$216.64 - $362.52 $20,147 - $33,714	-93 Reduced 1.37%	6,702 $1.73 Million
Q3 2021 Nov 09, 2021	SELL	$205.93 - $447.23 $858,316 - $1.86 Million	-4,168 Reduced 38.02%	6,795 $1.86 Million
Q2 2021 Aug 09, 2021	BUY	$113.32 - $241.49 $1.24 Million - $2.65 Million	10,963 New	10,963 $2.45 Million

358

38.4M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $29.6B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Bronte Capital Management Pty Ltd., based on Form 13F filings with the SEC.

Stay updated on Bronte Capital Management Pty Ltd. with notifications on news.